Mechanisms of innate and adaptive immunity to the Pfizer-BioNTech BNT162b2 vaccine

Despite the success of the BNT162b2 mRNA vaccine, the immunological mechanisms that underlie its efficacy are poorly understood. Here we analyzed the innate and adaptive responses to BNT162b2 in mice, and show that immunization stimulated potent antibody and antigen-specific T cell responses, as well as strikingly enhanced innate responses after secondary immunization, which was concurrent with enhanced serum IFNγ levels one day following secondary immunization. Notably, we found that natural killer cells and CD8 T cells in the dLNs are the major producers of this circulating IFNγ. Analysis of knockout mice revealed that induction of antibody and T cell responses to BNT162b2 was not dependent on signaling via TLRs 2, 3, 4, 5, 7, nor inflammasome activation, nor the necroptosis or pyroptosis cell death pathways. Rather, the CD8 T cell response induced by BNT162b2 was dependent on type I IFN-dependent MDA5 signaling. These results provide insights into the molecular mechanisms by which the BNT162b2 vaccine stimulates immune responses.